Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TFPI | P10646 | 1/20 | 0.48 |
| ▸ | BACE1 | P56817 | 11/20 | 0.47 |
| ▸ | BACE2 | Q9Y5Z0 | 2/20 | 0.47 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.46 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.46 |
| ▸ | CTSD | P07339 | 3/20 | 0.46 |
| ▸ | SYK | P43405 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30069083 | 0.94 | TFPI (0.52) | TFPIBACE1BACE2OPRM1OPRD1 | |
| SCHEMBL30069097 | 0.89 | TFPI (0.46) | TFPIBACE1BACE2OPRM1OPRD1 | |
| SCHEMBL30069086 | 0.88 | TFPI (0.61) | TFPI | |
| SCHEMBL30069130 | 0.86 | TFPI (0.50) | TFPIBACE1OPRM1OPRD1OPRK1 | |
| SCHEMBL30069080 | 0.86 | TFPI (0.50) | TFPIBACE1OPRM1OPRD1OPRK1 | |
| SCHEMBL29772030 | 0.85 | EGFR (0.47) | TFPIBACE1OPRM1OPRD1OPRK1 | |
| SCHEMBL30069133 | 0.85 | TFPI (0.48) | TFPIBACE1CTSD | |
| SCHEMBL30272505 | 0.84 | BACE1 (0.42) | BACE1OPRM1OPRD1CTSD | |
| SCHEMBL29771986 | 0.82 | BACE1 (0.56) | BACE1BACE2CTSD | |
| SCHEMBL29695472 | 0.81 | BACE1 (0.46) | BACE1BACE2OPRD1CTSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11524045-B2 | Peptides for dry eye disease | ALLYSTA PHARMACEUTICALS, INC. (US) | 2022-12-13 | — | — | US | claimed |
| US-11524045-B2 | Peptides for dry eye disease | ALLYSTA PHARMACEUTICALS, INC. (US) | 2022-12-13 | — | — | US | disclosed |